Abstract
Objective
Electroconvulsive therapy (ECT) is an important but underused treatment for severe psychiatric illnesses. We sought to examine the variability of ECT utilization at a population level and between several subgroups. We also sought to quantify the impact of the COVID-19 pandemic on ECT utilization.
Methods
We used population level data from Ontario to examine all ECT procedures administered from 1 January 2007 to 31 December 2023. Our primary measure of variability was the rate of ECT procedures per 1,000 population. We included three subgroups at time of ECT procedure: age (18–39, 40–64, and 65+), biologic sex (male/female), and Ontario Health (OH) region of residence (West, Central, Toronto, East, North West, North East). To quantify the impact of the COVID-19 pandemic we calculated the change in ECT rate from 2019 to 2020 (acute effect) and 2019 to 2023 (persistent effect).
Results
There were 450,381 ECT procedures delivered during the observation period. The yearly rate of ECT increased from 1.69 per 1,000 in 2007 to a peak of 3.08 per 1,000 in 2019. In 2023 the greatest per capita rates of ECT use were in the 65+ age group, female sex, and North East geographic region. In 2023, the rates of ECT use in different geographic regions ranged from 1.28 (North West) to 4.19 per 1,000 (North East). The COVID-19 pandemic resulted in an immediate 26.73%, followed by a 17.47% persistent drop in the rate of ECT with notable regional heterogeneity.
Conclusions
While ECT use increased over time, there were differences in this increase between age groups, biological sex, and geographic regions. The COVID-19 pandemic had significant immediate and persistent impacts on the rates of ECT use highlighting the need for ongoing population level monitoring of this important treatment.
Plain Language Summary Title
Electroconvulsive therapy volume in Ontario from 2007 to 2023
Plain Language Summary
We examined the rate of ECT delivered in Ontario, Canada from 2007 to 2023 to assess how this has changed over time. We also examined how different subgroups including age, sex, and geographic region have changed with respect to ECT volume. This period also included the COVID-19 pandemic, which we also assessed the impact of. Overall we found that ECT use increased over time but that the subgroups had different rates of increase. There were also large differences in the rate of ECT being delivered based on geographic regions. The COVID-19 pandemic immediately decreased the rate of ECT, but it also had longer lasting impact. Our results indicate that overall there has been an increase in the use of ECT, but that this increase varied by subgroup with significant differences particularly with respect to geographic region. The pandemic has also had a negative impact on ECT delivery both in the acute and longer-term.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
